Related Experiment Videos
Genomic characterization of the human trkC gene
N Ichaso1, R E Rodriguez, D Martin-Zanca
1Unidad de Medicina Molecular-Departamento de Medicina, Universidad de Salamanca, Spain.
Abstract:
The trkC gene encodes the high-affinity receptor for neurotrophin 3 and plays an important role in the regulation of the survival and differentiation of the mammalian nervous system and in heart development. Chromosomal rearrangements of trkC have been recently reported in congenital fibrosarcoma and it has been proposed that abnormal activation of this gene might be involved in tumor development. To facilitate the search for new mutations and rearrangements in the human trkC locus we have partially characterized its genomic organization by restriction mapping and have obtained the complete intron-exon structure. Our results show that human trkC consists of 20 exons, including two that encode the inserts present in the extracellular and tyrosine kinase domains, and another two that encode the carboxyl-terminal tail of the truncated TRKC isoform. Analysis of the 5' flanking region revealed the absence of TATA box, a very high content in C/G compatible with a CpG island and the presence of putative binding sites for the AP1, AP2, GC, ATF, BRN2, AML1 and Nkx2.5 transcription factors.
Insights
The trkC gene, crucial for nervous system and heart development, has 20 exons. Its genomic organization and 5' flanking region were characterized to aid in identifying new mutations linked to tumor development.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- The trkC gene encodes the receptor for neurotrophin 3, vital for nervous system and heart development.
- Chromosomal rearrangements in trkC are implicated in congenital fibrosarcoma, suggesting its role in tumor development.
Purpose of the Study:
- To characterize the genomic organization of the human trkC locus.
- To obtain the complete intron-exon structure of the human trkC gene.
- To analyze the 5' flanking region for regulatory elements.
Main Methods:
- Restriction mapping to partially characterize genomic organization.
- Determination of the complete intron-exon structure.
- Analysis of the 5' flanking region for transcription factor binding sites.
Main Results:
- The human trkC gene comprises 20 exons.
- Identified exons encode extracellular, tyrosine kinase, and carboxyl-terminal domains.
- The 5' flanking region lacks a TATA box, contains a CpG island, and shows putative transcription factor binding sites (AP1, AP2, GC, ATF, BRN2, AML1, Nkx2.5).
Conclusions:
- Detailed genomic characterization of the human trkC locus provides a foundation for mutation and rearrangement analysis.
- Understanding the trkC gene structure and regulatory elements is crucial for investigating its role in congenital fibrosarcoma and other cancers.